the future??, page-4

gavncath-

Just a comment on your assessment of the advantages of the NovoSorb material over granufoam for VAC dressings.

The trial protocol for BOTH the NovoSorb foam and the Granufoam dressings is the Granufoam protocol. That means that bits and pieces of dressing left behind at dressing change time must be removed from the wound bed for both materials.

The trial is not designed to show the superiority of NovoSorb, only to prove that it is no worse than Granufoam.

This may seem a rather modest goal, but it is what it is. The company wants to get this approved as a dressing material. If it were to be tested as a material to be implanted in tissue, then a whole different standard for approval would be employed and commercialization would be delayed.

I rather suspect that after completion of the implanted BTM studies are finished, at some point there would be a protocol approved for the dressing that would allow bits and pieces to remain in the wound. But not yet.